ornithine has been researched along with Lymphoma, Large B-Cell, Diffuse in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andersson, PO; Hasselblom, S; Karlsson, BG; Nilsson-Ehle, H; Pedersen, A; Pinto, R; Stenson, M | 1 |
Hara, S; Jimi, S; Matsumoto, T; Takamatsu, Y; Tamura, K; Uchiyama, M | 1 |
2 other study(ies) available for ornithine and Lymphoma, Large B-Cell, Diffuse
Article | Year |
---|---|
Serum nuclear magnetic resonance-based metabolomics and outcome in diffuse large B-cell lymphoma patients - a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Aspartic Acid; Biomarkers, Tumor; Cadaverine; Disease-Free Survival; Female; Humans; Hydroxybutyrates; Immunosuppressive Agents; Lymphoma, Large B-Cell, Diffuse; Lysine; Magnetic Resonance Spectroscopy; Male; Metabolomics; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Ornithine; Pilot Projects; Prognosis; Pyrrolidonecarboxylic Acid; Treatment Outcome; Valine; Young Adult | 2016 |
Simple and sensitive HPLC method for the fluorometric determination of methotrexate and its major metabolites in human plasma by post-column photochemical reaction.
Topics: Aged; Antimetabolites, Antineoplastic; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Humans; Limit of Detection; Linear Models; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Ornithine; Photolysis; Reproducibility of Results; Spectrometry, Fluorescence | 2012 |